PDF(Pubmed)
Abstract：
UNASSIGNED: This analysis estimated 2013 annual healthcare costs associated with the common mental disorders of mood and anxiety disorders and psychological symptoms within a representative sample of Australian women.
UNASSIGNED: Data from the 15-year follow-up of women in the Geelong Osteoporosis Study were linked to 12-month Medicare Benefits Schedule and Pharmaceutical Benefits Scheme data. A Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Non-patient edition identified common mental disorders and the General Health Questionnaire 12 assessed psychological symptoms. Participants were categorised into mutually exclusive groups: (1) common mental disorder (past 12 months), (2) subthreshold (no common mental disorder and General Health Questionnaire 12 score ⩾4) or (3) no common mental disorder and General Health Questionnaire 12 score <4. Two-part and hurdle models estimated differences in service use, and adjusted generalised linear models estimated mean differences in costs between groups.
UNASSIGNED: Compared to no common mental disorder, women with common mental disorders utilised more Medicare Benefits Schedule services (mean 26.9 vs 20.0, p < 0.001), had higher total Medicare Benefits Schedule cost ($1889 vs $1305, p < 0.01), received more Pharmaceutical Benefits Scheme prescriptions (35.8 vs 20.6, p < 0.001), had higher total Pharmaceutical Benefits Scheme cost ($1226 vs $740, p < 0.05) and had significantly higher annual out-of-pocket costs for Pharmaceutical Benefits Scheme prescriptions ($249 vs $162, p < 0.001). Compared to no common mental disorder, subthreshold women were less likely to use any Medicare Benefits Schedule service (89.6% vs 97.0%, p < 0.01), but more likely to use mental health services (11.4% vs 2.9%, p < 0.01). The subthreshold group received more Pharmaceutical Benefits Scheme prescriptions (mean 43.3 vs 20.6, p < 0.001) and incurred higher total Pharmaceutical Benefits Scheme cost ($1268 vs $740, p < .05) compared to no common mental disorder.
UNASSIGNED: Common mental disorders and subthreshold psychological symptoms place a substantial economic burden on Australian healthcare services and consumers.
UNASSIGNED: Data from the 15-year follow-up of women in the Geelong Osteoporosis Study were linked to 12-month Medicare Benefits Schedule and Pharmaceutical Benefits Scheme data. A Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Non-patient edition identified common mental disorders and the General Health Questionnaire 12 assessed psychological symptoms. Participants were categorised into mutually exclusive groups: (1) common mental disorder (past 12 months), (2) subthreshold (no common mental disorder and General Health Questionnaire 12 score ⩾4) or (3) no common mental disorder and General Health Questionnaire 12 score <4. Two-part and hurdle models estimated differences in service use, and adjusted generalised linear models estimated mean differences in costs between groups.
UNASSIGNED: Compared to no common mental disorder, women with common mental disorders utilised more Medicare Benefits Schedule services (mean 26.9 vs 20.0, p < 0.001), had higher total Medicare Benefits Schedule cost ($1889 vs $1305, p < 0.01), received more Pharmaceutical Benefits Scheme prescriptions (35.8 vs 20.6, p < 0.001), had higher total Pharmaceutical Benefits Scheme cost ($1226 vs $740, p < 0.05) and had significantly higher annual out-of-pocket costs for Pharmaceutical Benefits Scheme prescriptions ($249 vs $162, p < 0.001). Compared to no common mental disorder, subthreshold women were less likely to use any Medicare Benefits Schedule service (89.6% vs 97.0%, p < 0.01), but more likely to use mental health services (11.4% vs 2.9%, p < 0.01). The subthreshold group received more Pharmaceutical Benefits Scheme prescriptions (mean 43.3 vs 20.6, p < 0.001) and incurred higher total Pharmaceutical Benefits Scheme cost ($1268 vs $740, p < .05) compared to no common mental disorder.
UNASSIGNED: Common mental disorders and subthreshold psychological symptoms place a substantial economic burden on Australian healthcare services and consumers.
摘要：
■该分析估算了2013年与典型的澳大利亚女性样本中的情绪和焦虑障碍以及心理症状等常见精神障碍相关的年度医疗保健费用。
吉朗骨质疏松研究中15年随访女性的数据与12个月的医疗保险福利计划和药物福利计划数据相关联。精神障碍诊断和统计手册的结构化临床访谈，第四版,非患者版确定了常见的精神障碍，一般健康问卷12评估了心理症状。参与者被分为互斥组：（1）常见的精神障碍（过去12个月），（2）亚阈值（无常见的精神障碍和一般健康问卷12评分4）或（3）无常见的精神障碍和一般健康问卷12评分<4。两部分和障碍模型估计了服务使用的差异，和调整后的广义线性模型估计了组间成本的平均差异。
■与没有常见精神障碍相比，患有常见精神障碍的女性使用更多的医疗保险福利计划服务(平均26.9对20.0，p<0.001)，医疗保险福利计划总费用较高(1889美元vs1305美元，p<0.01)，收到更多药物福利计划处方(35.8对20.6，p<0.001)，药物福利计划的总费用较高（1226美元对740美元，p<0.05），药物福利计划处方的年度自付费用明显较高（249美元对162美元，p<0.001）。与没有常见的精神障碍相比，亚阈值女性不太可能使用任何医疗保险福利计划服务(89.6%vs97.0%，p<0.01),但更有可能使用心理健康服务(11.4%vs2.9%，p<0.01)。与没有常见的精神障碍相比，亚阈值组接受了更多的药物福利计划处方（平均43.3对20.6，p<0.001），并且产生了更高的总药物福利计划成本（1268美元对740美元，p<0.05）。
常见的精神障碍和阈值下的心理症状给澳大利亚的医疗服务和消费者带来了巨大的经济负担。
吉朗骨质疏松研究中15年随访女性的数据与12个月的医疗保险福利计划和药物福利计划数据相关联。精神障碍诊断和统计手册的结构化临床访谈，第四版,非患者版确定了常见的精神障碍，一般健康问卷12评估了心理症状。参与者被分为互斥组：（1）常见的精神障碍（过去12个月），（2）亚阈值（无常见的精神障碍和一般健康问卷12评分4）或（3）无常见的精神障碍和一般健康问卷12评分<4。两部分和障碍模型估计了服务使用的差异，和调整后的广义线性模型估计了组间成本的平均差异。
■与没有常见精神障碍相比，患有常见精神障碍的女性使用更多的医疗保险福利计划服务(平均26.9对20.0，p<0.001)，医疗保险福利计划总费用较高(1889美元vs1305美元，p<0.01)，收到更多药物福利计划处方(35.8对20.6，p<0.001)，药物福利计划的总费用较高（1226美元对740美元，p<0.05），药物福利计划处方的年度自付费用明显较高（249美元对162美元，p<0.001）。与没有常见的精神障碍相比，亚阈值女性不太可能使用任何医疗保险福利计划服务(89.6%vs97.0%，p<0.01),但更有可能使用心理健康服务(11.4%vs2.9%，p<0.01)。与没有常见的精神障碍相比，亚阈值组接受了更多的药物福利计划处方（平均43.3对20.6，p<0.001），并且产生了更高的总药物福利计划成本（1268美元对740美元，p<0.05）。
常见的精神障碍和阈值下的心理症状给澳大利亚的医疗服务和消费者带来了巨大的经济负担。
